Wird geladen...
Myocardial protection by heparin-based coacervate of FGF10
Heart disease is still the leading killer all around the world, and its incidence is expected to increase over the next decade. Previous reports have already shown the role of fibroblast growth factor10 (FGF10) in alleviating heart diseases. However, FGF10 has not been used to treat heart diseases b...
Gespeichert in:
| Veröffentlicht in: | Bioact Mater |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
KeAi Publishing
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732874/ https://ncbi.nlm.nih.gov/pubmed/33336117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bioactmat.2020.12.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|